                         SEQUENCE LISTING

<110>  Mainline Biosciences (Shanghai) Co., Ltd.
 
<120>  PEPTIDIC PAIN MODULATORS AND METHODS FOR PRODUCING AND USING THE 
       SAME

<130>  MLB-000501PC

<160>  115   

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  May be substituted with mono- or di-halide or with mono- or 
       di-alkyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Cys, Ala, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  optionally a cyclic structure is formed by a disulfide linkage

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  optionally a cyclic structure is formed by a disulfide linkage

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Optionally substituted Phe

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Phe, Leu, Met, Met(O), Gly, Nle, Ser, or substituted Ser

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Pro, Ala, Leu, Cys, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Cys, hCys, Pen, Ser, Leu, Ala, Val, or Aib

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Terminated with -L-R, where L is O, NH, or NMe; and R is benzyl 
       or substituted benzyl

<400>  1

Tyr Xaa Gly Phe Xaa Xaa Xaa Trp 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  May be substituted with mono- or di-halide or with mono- or 
       di-alkyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Cys, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Optionally substituted Phe

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Phe, Leu, Met, Met(O), Gly, Nle, Ser, or substituted Ser

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Cys, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Ser, Leu, Ala, Val, or Aib

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Terminated with -L-R, where L is O, NH, or NMe; and R is benzyl 
       or substituted benzyl

<400>  2

Tyr Xaa Gly Phe Xaa Xaa Xaa Trp 
1               5               


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  May be substituted with mono- or di-halide or with mono- or 
       di-alkyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Cys, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Optionally substituted Phe

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Phe, Leu, Met, Met(O), Gly, Nle, Ser, or substituted Ser

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Pro, Ala, or Leu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Cys, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Terminated with -L-R, where L is O, NH, or NMe; and R is benzyl 
       or substituted benzyl

<400>  3

Tyr Xaa Gly Phe Xaa Xaa Xaa Trp 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  May be substituted with mono- or di-halide or with mono- or 
       di-alkyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Cys, Ala, hCys, or Pen

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Optionally substituted Phe

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Phe, Leu, Met, Met(O), Gly, Nle, Ser, or substituted Ser

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Terminated with -L-R, where L is O, NH, or NMe; and R is benzyl 
       or substituted benzyl

<400>  4

Tyr Xaa Gly Phe Xaa Pro Leu Trp 
1               5               


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Methyl Substituted

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(2,4-(CF3)2)

<400>  5

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Methyl Substituted

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  6

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Methyl Substituted

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3-CF3)

<400>  7

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methyl substituted

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(4-CF3)

<400>  8

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(5-CF3)

<400>  9

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(6-CF3)

<400>  10

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-difluoro)

<400>  11

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-dichloro)

<400>  12

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-dibromo)

<400>  13

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  14
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(2,4-difluoro)

<400>  14

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(2,4-dichloro)

<400>  15

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  16
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(2,4-dibromo)

<400>  16

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  17
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(2,4-dimethyl)

<400>  17

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  18
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3',5'-dimethyl)

<400>  18

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  19
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  19

Tyr Cys Gly Phe Met Pro Cys Trp 
1               5               


<210>  20
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  20

Tyr Cys Gly Phe Met Cys Leu Trp 
1               5               


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  21

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  22

Tyr Cys Gly Phe Met Xaa Leu Trp 
1               5               


<210>  23
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  23

Tyr Xaa Gly Phe Met Pro Cys Trp 
1               5               


<210>  24
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  24

Tyr Xaa Gly Phe Met Cys Leu Trp 
1               5               


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  25

Tyr Xaa Gly Phe Met Pro Xaa Trp 
1               5               


<210>  26
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  26

Tyr Xaa Gly Phe Met Xaa Leu Trp 
1               5               


<210>  27
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  27

Tyr Xaa Gly Phe Met Pro Xaa Trp 
1               5               


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  28

Tyr Xaa Gly Phe Met Xaa Leu Trp 
1               5               


<210>  29
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  29

Tyr Xaa Gly Phe Met Pro Xaa Trp 
1               5               


<210>  30
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  30

Tyr Xaa Gly Phe Met Xaa Leu Trp 
1               5               


<210>  31
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  31

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  32
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  32

Tyr Cys Gly Phe Met Xaa Leu Trp 
1               5               


<210>  33
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  33

Tyr Xaa Gly Phe Met Pro Cys Trp 
1               5               


<210>  34
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  34

Tyr Xaa Gly Phe Met Cys Leu Trp 
1               5               


<210>  35
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  35

Tyr Cys Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  36
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  36

Tyr Cys Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  37
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  37

Tyr Cys Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  38
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated by -NH-Bn(3,5-(CF3)2)

<400>  38

Tyr Cys Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  39
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  39

Tyr Xaa Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  40
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  40

Tyr Xaa Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  41
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  41

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  42
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  42

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  43
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  43

Tyr Cys Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  44
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  44

Tyr Cys Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  45
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  45

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  46
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  46

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  47
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  47

Tyr Xaa Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  48
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  48

Tyr Xaa Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  49
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  49

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  50
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  50

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  51
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  51

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  52
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  52

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  53
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  53

Tyr Cys Gly Phe Met Pro Cys Trp 
1               5               


<210>  54
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  54

Tyr Cys Gly Phe Met Cys Leu Trp 
1               5               


<210>  55
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  55

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  56
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  56

Tyr Cys Gly Phe Met Xaa Leu Trp 
1               5               


<210>  57
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  57

Tyr Cys Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  58
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  58

Tyr Cys Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  59
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  59

Tyr Xaa Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  60
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  60

Tyr Xaa Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  61
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  61

Tyr Cys Gly Phe Met Pro Cys Trp 
1               5               


<210>  62
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  62

Tyr Cys Gly Phe Met Cys Leu Trp 
1               5               


<210>  63
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  63

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  64
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  64

Tyr Cys Gly Phe Met Xaa Leu Trp 
1               5               


<210>  65
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  65

Tyr Xaa Gly Phe Met Pro Cys Trp 
1               5               


<210>  66
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  66

Tyr Xaa Gly Phe Met Cys Leu Trp 
1               5               


<210>  67
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  67

Tyr Xaa Gly Phe Met Pro Xaa Trp 
1               5               


<210>  68
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  68

Tyr Xaa Gly Phe Met Xaa Leu Trp 
1               5               


<210>  69
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  69

Tyr Xaa Gly Phe Met Pro Xaa Trp 
1               5               


<210>  70
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  70

Tyr Xaa Gly Phe Met Xaa Leu Trp 
1               5               


<210>  71
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  71

Tyr Xaa Gly Phe Met Pro Xaa Trp 
1               5               


<210>  72
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  72

Tyr Xaa Gly Phe Met Xaa Leu Trp 
1               5               


<210>  73
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  73

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  74
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  74

Tyr Cys Gly Phe Met Xaa Leu Trp 
1               5               


<210>  75
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  75

Tyr Xaa Gly Phe Met Pro Cys Trp 
1               5               


<210>  76
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  76

Tyr Xaa Gly Phe Met Cys Leu Trp 
1               5               


<210>  77
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  77

Tyr Cys Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  78
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  78

Tyr Cys Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  79
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  79

Tyr Cys Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  80
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  80

Tyr Cys Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  81
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  81

Tyr Xaa Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  82
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  82

Tyr Xaa Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  83
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  83

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  84
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  84

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  85
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  85

Tyr Cys Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  86
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  86

Tyr Cys Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  87
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  87

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  88
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  88

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  89
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  89

Tyr Xaa Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  90
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  90

Tyr Xaa Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  91
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  91

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  92
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  penicillamine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  92

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  93
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  93

Tyr Xaa Gly Phe Xaa Pro Xaa Trp 
1               5               


<210>  94
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-penicillamine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  94

Tyr Xaa Gly Phe Xaa Xaa Leu Trp 
1               5               


<210>  95
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  95

Tyr Cys Gly Phe Met Pro Cys Trp 
1               5               


<210>  96
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  96

Tyr Cys Gly Phe Met Cys Leu Trp 
1               5               


<210>  97
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  97

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  98
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  98

Tyr Cys Gly Phe Met Xaa Leu Trp 
1               5               


<210>  99
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  99

Tyr Cys Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  100
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  100

Tyr Cys Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  101
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-cysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  101

Tyr Xaa Gly Phe Xaa Pro Cys Trp 
1               5               


<210>  102
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  102

Tyr Xaa Gly Phe Xaa Cys Leu Trp 
1               5               


<210>  103
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 3',5'-dimethyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  103

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  104
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 2',6'-dimethyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  104

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  105
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 3',5'-difluoro

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  105

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  106
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 3',5'-dichloro

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  106

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  107
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 3',5'-dibromo

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  107

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  108
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 2',6'-difluoro

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  108

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  109
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 2',6'-dichloro

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  109

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  110
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 2',6'-dibromo

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  110

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  111
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-isomer

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  111

Tyr Ala Gly Phe Met Pro Leu Trp 
1               5               


<210>  112
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 3',5'-dimethyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  112

Tyr Cys Gly Phe Met Cys Leu Trp 
1               5               


<210>  113
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 3',5'-dimethyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  113

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


<210>  114
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 2',6'-dimethyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(6)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  114

Tyr Cys Gly Phe Met Cys Leu Trp 
1               5               


<210>  115
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Phenyl ring of tyrosine substituted with 2',6'-dimethyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  forms a cyclic structure by a disulfide linkage between two 
       thiol-functional groups

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  homocysteine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  terminated with -NH-Bn(3,5-(CF3)2)

<400>  115

Tyr Cys Gly Phe Met Pro Xaa Trp 
1               5               


